Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Sep 2021. Module: Belgian module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1932751000172113 | COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932761000172110 | COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech (medicinal product) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932741000172111 | COVID-19 mRNA vaccin (BNT162b2) de Pfizer-BioNTech | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1932731000172116 | COVID-19 mRNA vaccin (BNT162b2) van Pfizer-BioNTech | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Is a | SARS-CoV-2 mRNA vaccine | true | Inferred relationship | Some | ||
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Has active ingredient | Tozinameran (substance) | true | Inferred relationship | Some | 1 | |
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Has supplier | BioNTech Manufacturing GmbH | true | Inferred relationship | Some | ||
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR